REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
20/04/2026
Voltar para busca
Dado oficial do USPTO
PINPOINT
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
PINPOINT
ST13
US500000088768179Classe
1, 5, 9, 40, 42
Pedido
88768179
Registro
6325211
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
35
Atualização mais recente
21/04/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
1, 5, 9, 40, 42
Data de depósito
21/01/2020
Data de registro
20/04/2021
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
20/04/2021
Última transação
21/04/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Foreign priority
Código do desenho
4
Tipo de titular
24
Localização do titular
CAMBRIDGE, GB
Examinador
MALYSZEK, KIMBERLY RAY
Unidade examinadora
N40
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
REVVITY DISCOVERY LIMITED
Horizon Discovery Limited
Representantes
Kevin A. Oliver Revvity, Inc.
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 9Classe 40Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Biological preparations in the nature of eukaryotic cellsisogenic cell lines and bio-production cell lines generated using base editing engineering for scientificlaboratory or medical research; reagentsplasmids and assays for scientificgenetic and medical research; genomic reference control samples for medical laboratory use; molecular biology research toolsin the nature of chemicalbiological and biochemical reagents; biological preparations in the nature of separate base editing components including mRNArRNAgRNAdeaminasenickaseribonucleotide protein (RNP) for use in scientificlaboratory or medical research; biological preparations in the nature of genetically modified cells and vectors for scientific and research purposes; biological and chemical reagents including complexes of these molecules for research and for clinical and industrial use
Classe 5
Diagnostic preparations and materials generated by the use of base editing components for medical purposes; chemical preparation for use in DNA analysis for medical purposes; biological preparations in the nature of DNARNA and parts thereof for medical purposes; biological preparations in the nature of DNA extracts for medical purposes; biological preparations in the nature of gene editing enzymes for medical purposes; biological preparations in the nature of protein cell lysatesgenomic DNA preparations and Formalin FixedParaffin Embedded (FFPE) engineered tumour tissue mimics for medical diagnostic use; biological preparations in the nature of biologicalbiochemical and chemical reagentsincluding living cellsgenetically modified cells and vectorsgenomic DNAcell cultures and mutant and normal isogenic cell line pairspeptidesproteins and nucleic acids or complexes of these molecules for medical use; all the aforesaid goods being medical preparations
Classe 9
collections of DNA and gene sequences for research and reference purposes provided as DNA microarrays and DNA chips
Classe 40
Treatment of biopharmaceutical materials; custom manufacture of cells and vectors for diagnosticmedical and commercial applications in relation to cell and gene therapies; consultancy and advisory services relating to the aforesaid services
Classe 42
Custom cell-line engineering services; gene base-editing services for research purposes; gene engineering services; research and development services in the creation of databases or collections of information on biologicals including cells and cell lines for research purposes; creating and providing databases or collections of information on normal and mutated genes for research purposes; providing DNA reference standards for research purposes; providing DNA reference databases being collections of DNA and gene sequences for research purposes; research on cell line models; contract research on cell line models; research and development services relating to targeting therapies to individuals; establishing patient genotypes for research or analysis purposes; research and development services relating to combining therapies for individuals; research and development relating to reagents; disease modelling for research purposes; design of clinical trials for research purposes; research and development in re-positioning existing drugs from other therapeutic indications; consultancy and advisory services relating to the aforesaid services; all of the aforesaid services relating to biological and medical research and research and development in the field of cells and cell therapiesgenome editinggenetic engineering and gene therapies
Publicações
Histórico de despachos e eventos da marca no USPTO.
35 publicações encontradas
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
05/03/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
12/07/2024
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
12/07/2024
EWOR
TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
12/07/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
12/07/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
12/07/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
12/07/2024
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
12/07/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
20/04/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/02/2021
PUBO
PUBLISHED FOR OPPOSITION
02/02/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
13/01/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
28/12/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
26/12/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
26/12/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
26/12/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
29/09/2020
GNRT
NON-FINAL ACTION E-MAILED
29/09/2020
CNRT
NON-FINAL ACTION WRITTEN
29/09/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
28/09/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
26/09/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
26/09/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
04/06/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
04/06/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
04/06/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
09/04/2020
GNRT
NON-FINAL ACTION E-MAILED
09/04/2020
CNRT
NON-FINAL ACTION WRITTEN
09/04/2020
DOCK
ASSIGNED TO EXAMINER
08/04/2020
AMPX
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
30/03/2020
ALIE
ASSIGNED TO LIE
26/03/2020
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
20/03/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
25/01/2020
NWAP
NEW APPLICATION ENTERED
24/01/2020
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace PINPOINT ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.